SCHEMBL1008928

SCHEMBL1008928

Oc1ccccc1Nc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 5/20 0.68
MAPT P10636 5/20 0.56
TDP1 Q9NUW8 4/20 0.56
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
KDM4E B2RXH2 3/20 0.56
GAA P10253 2/20 0.56
RECQL P46063 2/20 0.56
GLA P06280 1/20 0.56
ALDH1A1 P00352 6/20 0.54
LMNA P02545 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
HSD17B10 Q99714 4/20 0.52
ALOX15 P16050 4/20 0.50
L3MBTL1 Q9Y468 4/20 0.50
TSHR P16473 3/20 0.50
CYP3A4 P08684 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29720861 1.00 CXCR2 (0.68) CXCR2MAPTTDP1MEN1KMT2A
SCHEMBL27435565 0.98 CXCR2 (0.66) CXCR2MAPTTDP1MEN1KMT2A
SCHEMBL11000813 0.95 CXCR2 (0.63) CXCR2MAPTTDP1MEN1KMT2A
SCHEMBL10741108 0.95 CXCR2 (0.63) CXCR2MAPTTDP1MEN1KMT2A
SCHEMBL1920750 0.92 CXCR2 (0.59) CXCR2MAPTTDP1MEN1KMT2A
SCHEMBL6760764 0.86 MAPT (0.55) CXCR2MAPTTDP1MEN1KMT2A
SCHEMBL1921886 0.86 CXCR2 (0.53) CXCR2MAPTTDP1MEN1KMT2A
SCHEMBL29165703 0.84 CXCR2 (0.52) CXCR2MAPTTDP1MEN1KMT2A
SCHEMBL27294589 0.84 MAPT (0.56) CXCR2MAPTTDP1MEN1KMT2A
SCHEMBL304891 0.84 CXCR2 (0.54) CXCR2MAPTTDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103275769-B High-cleanness environment-friendly alcohol ether fuel for car LU JIAZHENG 2015-05-13 CN claimed
US-8853207-B2 Heterocyclic pyrazole compounds, method for preparing the same and use thereof DEVELOPMENT CENTER FOR BIOTECHNOLOGY (TW) 2014-10-07 US claimed
CN-103703005-A Tricyclic inhibitors of kinases ABBOTT LAB 2014-04-02 CN claimed
US-20130274255-A1 HETEROCYCLIC PYRAZOLE COMPOUNDS, METHOD FOR PREPARING THE SAME AND USE THEREOF DEVELOPMENT CENTER FOR BIOTECHNOLOGY (TW) 2013-10-17 US claimed
CN-103275769-A High-cleanness environment-friendly alcohol ether fuel for car LU JIAZHENG 2013-09-04 CN claimed
CN-101790413-A Separation membrane comprising polyethersulfone, process for production thereof, and stock solution for production of film KAWASAKI HEAVY IND LTD 2010-07-28 CN claimed
CN-1052000-C Process for the preparation of alkylimidazolidone (meth)acrylateds ATOCHEM ELF SA (FR) 2000-05-03 CN claimed
CN-1051999-C Process for the preparation of alkylimidazolidone (meth)acrylate(s) ATOCHEM ELF SA (FR) 2000-05-03 CN claimed
CN-1050353-C Process for preparing alkylimidazolidone (meth) acrylates ATOCHEM ELF SA (FR) 2000-03-15 CN claimed
CN-1179419-A Process for manufacture of alkylimidazolidone (methyl) acrylates ATOCHEM ELF SA (FR) 1998-04-22 CN claimed
CN-1127750-A Process for the preparation of alkylimidazolidone (meth)acrylateds ATOCHEM ELF SA (FR) 1996-07-31 CN claimed
CN-1105992-A Process for preparing alkylimidazolidone (meth) acrylates ATOCHEM ELF SA (FR) 1995-08-02 CN claimed
CN-1097742-A The method for preparing alkyl imidazoline ketone (methyl) acrylate ATOCHEM ELF SA (FR) 1995-01-25 CN claimed
US-4696756-A SILOXANE BLEND TORAY SILICONE CO., LTD. (JP) 1987-09-29 US claimed
US-4683319-A POLYSILOXANE REACTED WITH AROMATIC AMINOPHENOL, VISCOSITY STABILIZER TORAY SILICONE CO., LTD. (JP) 1987-07-28 US claimed
JP-55038355-A None JP disclosed
JP-4220442-A None JP disclosed
US-4086405-A ZINC OR NICKEL-CADMIUM ELECTRODES, POLYVINYL ACETAL SEPARATOR COMPAGNIE GENERALE D'ELECTRICITE S.A. (FR) 1978-04-25 US disclosed
US-3979411-A FUNGICIDES, INSECTICIDE, MITICIDES BAYER AKTIENGESELLSCHAFT (DT) 1976-09-07 US disclosed
US-3960886-A Substituted N-arylanilines STERLING DRUG INC. (US) 1976-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130274255-A1 HETEROCYCLIC PYRAZOLE COMPOUNDS, METHOD FOR PREPARING THE SAME AND USE THEREOF RET, FLT3, FGFR1 CXCR2 434/4885MAPT 2422/4885TDP1 2062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.